2020

1. Drugsniper, a tool to exploit loss-of-function screens, identifies CREBBP as a predictive biomarker of VOLASERTIB in small cell lung carcinoma (SCLC)

   Cancers, Vol. 12, Núm. 7, pp. 1-18